|
|
Post by joeypotsandpans on Oct 12, 2017 6:30:06 GMT -5
|
|
|
|
Post by dh4mizzou on Oct 12, 2017 6:57:04 GMT -5
I had to read it twice to make sure it was a MF piece. 
But how sad is it that a totally balanced article could even be considered "bullish" for a stock? Is that how low MF has gone? |
|
|
|
Post by boca1girl on Oct 12, 2017 7:29:26 GMT -5
I agree, it was nice to see a balanced article from MF, but he said he would not buy the dip. He would take a wait and see approach. “But to quote a non-Russian proverb, "The proof is in the pudding." I'd like to see at least one full quarter of sales results with the label change for Afrezza in effect. I'm not negative about MannKind's prospects, but my optimism is tempered with a heavy dose of caution. I won't personally buy the dip with MannKind stock. However, if the company shows that it really will be able to kick Afrezza sales into high gear, this biotech, once written off by many, will definitely warrant serious consideration.” But coming from the source, it’s great. I expect Cramer will come out with a similar statement after the next positive news item from MNKD. |
|
|
|
Post by joeypotsandpans on Oct 17, 2017 22:55:08 GMT -5
Here is his most recent follow up article on MNKD: www.fool.com/investing/2017/10/17/is-mannkinds-debt-a-ticking-time-bomb.aspxI have to say that when put in the right context as he states considering 26yrs. $165M outstanding doesn't seem like that much all things considered. The ticking time bomb headline is a bit dramatic though lol, you could just as easily say it's potentially a ticking time bomb for the naysayers  |
|
|
|
Post by straightly on Oct 18, 2017 9:04:42 GMT -5
Here is his most recent follow up article on MNKD: www.fool.com/investing/2017/10/17/is-mannkinds-debt-a-ticking-time-bomb.aspxI have to say that when put in the right context as he states considering 26yrs. $165M outstanding doesn't seem like that much all things considered. The ticking time bomb headline is a bit dramatic though lol, you could just as easily say it's potentially a ticking time bomb for the naysayers Any serious long on this board knows of MNKD's debt and would seriously consider the article bullish. For one: we would be very close to have more revenues than interests in Q3 and definitely have more revenues than interests in Q4! Go MNKD. Onward and upward. |
|
|
|
Post by joeypotsandpans on Oct 19, 2017 8:02:48 GMT -5
|
|
|
|
Post by joeypotsandpans on Nov 9, 2017 1:30:25 GMT -5
|
|
|
|
Post by dreamboatcruise on Nov 10, 2017 17:55:43 GMT -5
He did a very poor job of talking about the share authorization. More time was spent talking about 12u cartridges. Investors are left reading between the lines, or perhaps projecting their own desires/concerns into the void. Some look at the potential for dilution it represents, and for others it strengthens their conviction that Merck must be buying MNKD for billions. |
|
|
|
Post by babaoriley on Nov 10, 2017 19:27:06 GMT -5
He did a very poor job of talking about the share authorization. More time was spent talking about 12u cartridges. Investors are left reading between the lines, or perhaps projecting their own desires/concerns into the void. Some look at the potential for dilution it represents, and for others it strengthens their conviction that Merck must be buying MNKD for billions. "He did a very poor job of talking about the share authorization." In my opinion, DBC, so did you. |
|
|
|
Post by dreamboatcruise on Nov 10, 2017 19:51:07 GMT -5
He did a very poor job of talking about the share authorization. More time was spent talking about 12u cartridges. Investors are left reading between the lines, or perhaps projecting their own desires/concerns into the void. Some look at the potential for dilution it represents, and for others it strengthens their conviction that Merck must be buying MNKD for billions. "He did a very poor job of talking about the share authorization." In my opinion, DBC, so did you. Unlike him, at least I'm putting in the effort to try to get my point across. I'll take your comment as encouragement for me to try to do better in the run up to the vote |
|
|
|
Post by mnholdem on Nov 10, 2017 20:42:50 GMT -5
A piece of advice? Be bold, be brief...and then be done - aka quality over quantity.  |
|
